Q3 2026 Church & Dwight Earnings Conference Call - CHURCH & DWIGHT CO INC

Explicit Guidance:

• FY2026 Organic Sales Growth: Expected at approximately 5% (high end of prior 4–5% range).
• FY2026 Adjusted EPS: Expected to increase approximately 7% (tightened on prior 6–8% range).
• FY2026 Adjusted Gross Margin: Expected to expand by approximately 100 basis points, inclusive of $150 million in inflation headwinds (roughly $50M more than original FY2026 outlook).
• FY2026 Marketing Investment: Expected to remain at approximately 11.9% of sales (previously 11.9%, now stated as ~11% in guidance summary).
• FY2026 SG&A: Expected to remain above 2025 levels, driven by acquisition amortization, international growth investments, and AI capability building.
• FY2026 Adjusted Tax Rate: Expected to be approximately 21%.
• FY2026 Capital Expenditures: Full-year CapEx expected to be approximately $125 million (~2% of sales).
• FY2026 Cash from Operations: Expected to be approximately $1.175 billion.
• Q4 2026 Organic Sales Growth: Expected at approximately 4%.
• Q4 2026 Adjusted EPS: Expected to increase 17–19% year-over-year.
• FY2027 Outlook: Management expects organic sales growth and margin expansion to continue, with a formal update on 2030 growth initiatives to be provided at the Analyst Day in January 2027.
• Oil Price Assumption: Guidance assumes a crude oil price of approximately $100 per barrel (WTI).

Business-Segment Outlook:

• U.S. Consumer: Confidence remains in growth driven by Arm & Hammer (laundry and litter gaining share), TheraBreath (mouthwash and toothpaste), and Waterpik. TheraBreath mouthwash household penetration is low (14% vs. 65% category), indicating significant runway; toothpaste repeat rates are closing in on 30%.
• International: Driven by nine double-digit growth brands including TheraBreath, Batiste, Touchland, and OxiClean. Global e-commerce represents 25.9% of consumer sales.
• SPD Division: Expecting continued 11th+ straight quarter of organic growth; volume and price/mix expected to drive performance.
• TheraBreath: Launch of "complete rinse" and portable sachets in the U.S.; global expansion continuing, including new introduction in Japan. Oral care expansion (cleansers, toothpaste) expected to drive share gains in 2027–2029.
• Touchland: Full-year 2026 sales expected to be "flattish" (Q3 slightly negative), but expects growth to resume in 2027 driven by expanded U.S. distribution and international rollouts (UK/Australia) with plans for broader distribution in 2027–2028.
• Hero Acne: Cleanser launch expected to lead share gains; consumption outpaced patch category; low household penetration (10% vs. 30% category) suggests high runway.
• Arm & Hammer: 2027 product launch expected in the U.S.; 2028 innovation portfolio described as "encouraged," particularly in household categories.

Market and Competitive Outlook:

• Category Growth: Forecasts category growth at approximately 2.5% for 2027 (vs. ~2% start-of-year expectation), driven by strong Q1–Q3 performance.
• Pricing and Promotions: Expect promotional levels to eventually decrease as inflation remains structural and non-transitory, though currently elevated due to tariff refunds. Elasticities remain strong; volume reacts positively to promotions.
• E-commerce: Continues to be a major growth driver; portfolio is shifting toward higher online exposure brands (Touchland, TheraBreath, Miss Mouth) while divesting low-exposure businesses.
• Share Gains: Confident in continued market share expansion across household and personal care portfolios, particularly in value segments (laundry, litter) during the current economic environment.

Macro / Industry Outlook:

• Inflation: FY2026 outlook includes ~$150M inflation cost impact; expects inflationary pressure to persist into 2027.
• Transportation: Current rate spikes (up 40% spot) linked to driver shortages; management views this as potentially structural for a period but believes supply/demand will balance over time to 3–5% long-term average.
• Commodities: Paused hedging briefly due to volatility but has resumed hedging for 2027; currently "slightly more hedged" than the same time last year.
• Consumer Environment: Acknowledges stretched consumer wallets and elevated disposable income pressure, but believes value propositions and innovation will sustain volume growth.
• Rates/Tariffs: Management notes tariff refund benefits of ~$15M in Q3 and ~$5M in Q4.

Strategic Initiatives:

• 2030 Growth Plan: Management advancing initiatives to expand Arm & Hammer, scale TheraBreath/oral care, and grow the international business; formal update expected at the January 2027 Analyst Day.
• New Product Launches:
  • 2027: Household innovations expected; specific Arm & Hammer category entry in U.S. to be announced in January.
  • 2028: Significant household innovation portfolio rollout.
• International Expansion: Aggressive rollout of Touchland and TheraBreath in Europe and Asia; leveraging acquired distributor (Grafico) to accelerate brand penetration (e.g., Japan).
• M&A: Criteria remains focused on #1/#2 brands with asset-light models; more willing to acquire full businesses (including plants/back offices) for international expansion. International M&A focus increasing; domestic M&A focus decreasing.
• Capex: $125M expected for FY2026, focusing on productivity and growth initiatives.
• Capital Allocation: New $1B share repurchase program authorized (no expiration date) to replace prior authorization, providing flexibility for acquisitions and investments.

Risks and Headwinds to Outlook:

• Inflation and Costs: Persistent inflation and elevated transportation rates (linked to Middle East conflict and driver shortages) remain key headwinds.
• Competitive Pressure: Increased promotional intensity in categories (e.g., laundry, litter) due to consumer sensitivity and tariff refund usage by peers.
• Execution Risk: Slower-than-expected growth in Touchland in 2026 due to competitive products in non-competitor channels.
• Macro Uncertainty: Volatility in oil prices and global supply chains; potential for inflation to become more structural, requiring price increases if productivity and RGM are insufficient.
• FX: Currency fluctuations and lower price/mix impact noted in International segment (partial offset to volume growth).

Management Tone on the Future:

• Confidence: High confidence in delivering an improved 2026 outlook and entering 2027 with momentum.
• Optimism: Described as "very optimistic" about 2027 and the broader 2030 growth initiatives; views innovation as a core competency with "broad-based" potential.
• Strategic Pivot: Emphasis on "productivity first," followed by RGM/promotion management, and then pricing if inflation remains structural.
• Long-term View: Reiterated commitment to gross margin expansion as a lifeblood of the organization; expects fixed cost leverage to improve in 2027 as organic growth becomes reported growth.

Miscellaneous:

• Analyst Day: Scheduled for late January 2027 to provide detailed updates on 2030 growth initiatives, including new category launches and licensing/reacquisition strategies.
• Licensing/Incubator: One brand already reacquired; 2–3 additional licensing categories under review for potential in-house reacquisition if thresholds are met; some brands may remain licensed if better suited for external incubation.
• Distribution: Touchland distribution expansion confirmed in U.S. mass and beauty classes of trade; international regulatory barriers being cleared rapidly.